Collecting Dietary Information From People Undergoing Cancer Treatment

Active, not recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

May 31, 2022

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Receiving Allogeneic Hematopoietic Cell Transplants
Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER